137 related articles for article (PubMed ID: 9369381)
1. Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors.
Kampa M; Bakogeorgou E; Hatzoglou A; Damianaki A; Martin PM; Castanas E
Eur J Pharmacol; 1997 Sep; 335(2-3):255-65. PubMed ID: 9369381
[TBL] [Abstract][Full Text] [Related]
2. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.
Hatzoglou A; Bakogeorgou E; Castanas E
Eur J Pharmacol; 1996 Jan; 296(2):199-207. PubMed ID: 8838457
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line.
Hatzoglou A; Bakogeorgou E; Hatzoglou C; Martin PM; Castanas E
Eur J Pharmacol; 1996 Aug; 310(2-3):217-23. PubMed ID: 8884220
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S1-casomorphin amide).
Kampa M; Loukas S; Hatzoglou A; Martin P; Martin PM; Castanas E
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):903-8. PubMed ID: 8920997
[TBL] [Abstract][Full Text] [Related]
5. The occurrence of different kappa opioid receptors (K1 and K2) in frog (Rana esculenta) brain membranes.
Benyhe S; Varga E; Borsodi A; Wollemann M
Acta Physiol Hung; 1990; 76(4):291-4. PubMed ID: 1966577
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
Sánchez-Blázquez P; Garzón J
Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
[TBL] [Abstract][Full Text] [Related]
7. Beta-casomorphin-5 stimulates neurite outgrowth in a mouse neuroblastoma cell line (Neuro-2a).
Sakaguchi M; Murayama K; Yabe K; Satoh M; Takeuchi M; Matsumura E
Neurosci Lett; 1998 Jul; 251(2):97-100. PubMed ID: 9718983
[TBL] [Abstract][Full Text] [Related]
8. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
Hayes AG; Sheehan MJ; Tyers MB
Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): evidence for an interaction between the two systems.
Panagiotou S; Hatzoglou A; Calvo F; Martin PM; Castanas E
J Cell Biochem; 1998 Dec; 71(3):416-28. PubMed ID: 9831078
[TBL] [Abstract][Full Text] [Related]
10. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
Chang KJ; Hazum E; Cuatrecasas P
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
[TBL] [Abstract][Full Text] [Related]
11. Kappa1-opioid binding sites are the dominant opioid binding sites in surgical specimens of human pheochromocytomas and in a human pheochromocytoma (KAT45) cell line.
Kampa M; Margioris AN; Hatzoglou A; Dermitzaki I; Denizot A; Henry JF; Oliver C; Gravanis A; Castanas E
Eur J Pharmacol; 1999 Jan; 364(2-3):255-62. PubMed ID: 9932731
[TBL] [Abstract][Full Text] [Related]
12. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
[TBL] [Abstract][Full Text] [Related]
13. The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell line.
Kampa M; Papakonstanti EA; Alexaki VI; Hatzoglou A; Stournaras C; Castanas E
Exp Cell Res; 2004 Apr; 294(2):434-45. PubMed ID: 15023532
[TBL] [Abstract][Full Text] [Related]
14. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
Fang FG; Fields HL; Lee NM
J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic opioid receptors in the portal vein of the rabbit.
Szabo B; Wichmann T; Starke K
Eur J Pharmacol; 1987 Jul; 139(1):103-10. PubMed ID: 2820753
[TBL] [Abstract][Full Text] [Related]
16. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
Sbacchi M; La Regina A; Petrillo P; Tavani A
NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999
[TBL] [Abstract][Full Text] [Related]
17. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
Sofuoglu M; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1991 May; 257(2):676-80. PubMed ID: 1851833
[TBL] [Abstract][Full Text] [Related]
18. Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence.
Shen KF; Crain SM
Brain Res; 1994 Feb; 636(2):286-97. PubMed ID: 8012813
[TBL] [Abstract][Full Text] [Related]
19. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
[TBL] [Abstract][Full Text] [Related]
20. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
Kirby GC; McQueen DS
Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
